These samples are a quick look at how I translate dense scientific information into audience-ready landing pages, email series, and campaign updates that move biotech audiences toward conversations.
These samples span landing pages, multi-email company introductions, and ongoing updates designed to keep high-value audiences informed and engaged. Click on any image preview to see a full-sized screenshot.
AlphaRose is developing RNA-based treatments for rare genetic diseases. I wrote a five-part email series that introduced the company’s mission, spotlighted their lead therapeutic, and framed the investment opportunity in clear, patient-first language for prospective investors.
View full project
Innovega is building smart glasses that help low vision and legally blind patients see with near 20/20 vision. I created a five-email investor sequence that explained the technology, highlighted the leadership team, and laid out the growth story and reasons to invest in an accessible way.
View full project
Cytonics needed a landing page to support their equity crowdfunding campaign for a novel osteoarthritis treatment. I partnered with their team to craft and optimize long-form copy that clearly explained the science, framed the market opportunity, and helped them raise over $6.2M from more than 1,500 investors.
View full project
For Innovega’s equity crowdfunding campaign, I wrote and refined the copy on their investor landing page. The page had to educate readers on a complex hardware-plus-software platform, while building confidence in the team and traction.
View full project
Vita Imaging needed a campaign page that could carry both the technical story of their cancer detection platform and the investment case. I developed copy that clarified the clinical problem, explained the technology in investor-friendly terms, and supported a raise of more than $285K from over 275 investors.
View full project
To keep current and prospective investors engaged, Innovega requested a series of themed updates for their campaign page. I wrote progress stories around product development, patient impact, partnerships, and milestones, each crafted to reinforce momentum and make it easy for readers to see why now was the right time to invest.
View full projectWhether you’re planning an investment round, gearing up to release key data, or simply need clearer education for investors and clinicians, I can help.
Share a bit about your product, platform, and upcoming milestones. I’ll recommend the package that fits best for a realistic launch on your timeline.